HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Using Network Pharmacology and Animal Experiment to Investigate the Therapeutic Mechanisms of Polydatin against Vincristine-Induced Neuropathic Pain.

AbstractBackground:
Polydatin (PD) is the primary active compound in Polygonum cuspidatum Sieb and has been demonstrated to exert anti-inflammatory and neuroprotective activities. In the present study, we aimed to explore the therapeutic mechanisms of PD against chemotherapy-induced neuropathic pain.
Methods:
The putative targets of PD were obtained from the CTD and SwissTargetPrediction databases. Neuropathic pain- and VIN-related targets were collected from the CTD and GeneCards databases. Subsequently, the intersection targets were obtained using the Venn tool, and the protein-protein interaction (PPI) was constructed by the STRING database. GO and KEGG enrichment analyses were performed to investigate the biological functions of the intersection targets. Further, a rat model of VIN-induced neuropathic pain was established to confirm the reliability of the network pharmacology findings.
Results:
A total of 46 intersection targets were identified as potential therapeutic targets, mainly related to neuroinflammation. KEGG pathway analysis indicated that the IL-17 signaling pathway was involved in the mechanism of the antinociceptive effect of PD. PPI network analysis indicated that RELA, IL-6, TP53, MAPK3, and MAPK1 were located at crucial nodes in the network. Additionally, PD exerted an antinociceptive effect by increasing the nociceptive threshold. The results of qRT-PCR, western blot, and immunohisochemistry indicated that PD inhibited the IL-6, TP53, and MAPK1 levels in VIN-induced neuropathic pain rats.
Conclusions:
Overall, this research provided evidence that suppressing inflammatory signaling pathways might be a potential mechanism action of PD's antinociceptive effect against VIN-induced neuropathic pain.
AuthorsPeng Xi, Rui Mao, Shiyan Wu, Lei Liu, Ceng Cai, Lei Lu, Cailin Zhang, Yimei Li
JournalMediators of inflammation (Mediators Inflamm) Vol. 2022 Pg. 6010952 ( 2022) ISSN: 1466-1861 [Electronic] United States
PMID36281234 (Publication Type: Journal Article)
CopyrightCopyright © 2022 Peng Xi et al.
Chemical References
  • Vincristine
  • polydatin
  • Interleukin-6
  • Interleukin-17
  • Drugs, Chinese Herbal
  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Analgesics
Topics
  • Rats
  • Animals
  • Vincristine
  • Animal Experimentation
  • Interleukin-6 (metabolism)
  • Interleukin-17
  • Network Pharmacology
  • Reproducibility of Results
  • Neuralgia (chemically induced, drug therapy)
  • Drugs, Chinese Herbal (pharmacology)
  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Analgesics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: